推薦文章

子宮移植:2024年的現狀

自然週期vs誘導排卵

在所有年齡層 囊胚持續著床率比較

誘導排卵成效與下列有關

自然週期vs誘導排卵

自然週期vs誘導排卵 誘導排卵並不明顯提高胚胎染色體異常率 
自然週期vs誘導排卵 胚胎異常率均隨女性年齡而增加, 
自然週期vs誘導排卵 整倍體囊胚的植入率相同。
誘導排卵對胚胎非整倍體風險或胚胎生殖潛力沒有明顯副作用。
• Embryonic aneuploidy rates are equivalent in natural cycles and gonadotropin-stimulated cycles
• Aneuploidy rates were equivalent in unstimulated and stimulated IVF cycles. 
• The prevalence of aneuploidy in natural cycles increased with the age of the female partner in a manner identical to that seen in stimulatedIVF cycles. 
• Implantation rates of euploid blastocysts were equivalent in natural and stimulated IVF cycles.
• No measurable toxic effect of gonadotropin administration on aneuploidy risk or embryonic reproductive potential. 
 
 
• The overall sustained implantation rate (SIR) did not differ for patients in the natural cycle group (60.0%) as compared tosuperovulatory controls (63.8%)
• Patients less than 35 years of age had an SIR of 61.7% in the natural cycle group versus 66.5% in the control group (P=.45). 
• There were no differences in SIR between patients that were 35 to 37 years of age in natural cycle (53.3%) versus gonadotropin controlcycle patients (62.9%, P=.52). 
• Patients between the ages of 38 and 40 had SIR of 69.2% and 60.2%, in study and control groups, respectively (P=.65). 
• The SIR similarly did not vary for patients ages 41–42 in the natural cycle group and the superovulatory control group (33.3% vs. 61.4%, P=.33), or greater than 42 years of age (50.0% vs. 50.0%, P>.99).